R&D News | pharmaphorum

News

Gilde wraps up fresh health investment fund worth €600m

Netherlands-based investment group Gilde Healthcare has raised €600 million ($658 million) for a new transatlantic fund intended to support innovative ventures in digital

News

Cancer vaccines come to the fore at AACR

This year’s American Association of Cancer Research (AACR) annual meeting saw a clutch of new studies on therapeutic vaccines that suggest the approach is starting to gain

News

GSK bolsters respiratory pipeline with Bellus Health buy

GSK has agreed to acquire Canada’s Bellus Health for around $2 billion, bolting on a late-stage drug candidate for chronic refractory cough.

News

Call for ‘more trial, less error’ in study diversity

A report from a UK think tank focused on the impact of longevity on society has found that people aged over 60 are still poorly represented in clinical trials – even thoug

News

Regeneron chair Vagelos steps down at 93

Biopharma legend P. Roy Vagelos will step down as chairman of Regeneron Pharmaceuticals after 29 years in June, at the age of 93.

News

Complement raises €72m for geographic atrophy gene therapy

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing

Gilde wraps up fresh health investment fund worth €600m

Cancer vaccines come to the fore at AACR

GSK bolsters respiratory pipeline with Bellus Health buy

Call for ‘more trial, less error’ in study diversity

Regeneron chair Vagelos steps down at 93

Complement raises €72m for geographic atrophy gene therapy

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks